Multifactorial analysis of radiochemical purity in high-activity <sup>177</sup>Lu-labeled theranostics: impact of precursor source, <sup>177</sup>Lu form, and production parameters. [PDF]
Hunt W +9 more
europepmc +1 more source
Reply to "Exploring Bacteria-Based Cancer Immunotherapy"-Comment on "Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics". [PDF]
Miyako E.
europepmc +1 more source
The promising potential of camelid nanobodies for nuclear medicine. [PDF]
Biersack HJ +5 more
europepmc +1 more source
BLyS/APRIL dual inhibition by telitacicept for refractory pemphigus vulgaris combined with hepatocellular cancer. [PDF]
Chen W, Xu J, Zhang Y.
europepmc +1 more source
Improving Equitable Cancer Treatment in Australia: The Case for Theranostics in the Northern Territory. [PDF]
Morigi JJ, McGavin S.
europepmc +1 more source
Synergistic chemodynamic and metabolic reprogramming-based cancer therapy by CuO@HA nanozymes with oxygen vacancy. [PDF]
Wang W +9 more
europepmc +1 more source
An integrated ultrasound-guided focused ultrasound system enables spatiotemporal control of thermal gene activation in engineered immune cells. [PDF]
Lee J +6 more
europepmc +1 more source
A powerful bioorthogonal toolbox boosting the development of immune theranostics. [PDF]
Liu S, Hua C, Li X, Yuan P, Xing B.
europepmc +1 more source
Differential response to Janus kinase inhibitors in refractory livedoid vasculopathy: Biomarker-guided therapy may improve clinical response. [PDF]
Yu G +5 more
europepmc +1 more source

